JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuk, B.
Right arrow Articles by Danhof, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuk, B.
Right arrow Articles by Danhof, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MIDAZOLAM HYDROCHLORIDE

Vol. 284, Issue 1, 202-207, 1998

Relevance of Arteriovenous Concentration Differences in Pharmacokinetic-Pharmacodynamic Modeling of Midazolam

B. Tuk, V. M. M. Herben, J. W. Mandema and M. Danhof

Leiden/Amsterdam Center for Drug Research, Division of Pharmacology, 2300 RA Leiden, The Netherlands (B.T., V.M.M.H., M.D.), and Stanford University School of Medicine, Department of Anesthesia, Stanford, California (J.W.M.)

In the present investigation, the extent of arteriovenous concentration differences of midazolam in rats was quantified, and the consequences of these differences on the pharmacodynamic estimates were determined. The arterial concentration-effect relationships were analyzed by a traditional-effect compartment model that characterizes the delay between blood and the effect site with the rate constant keo. Venous concentration-effect relationships where analyzed according to the traditional model and an extended-effect compartment model that, by incorporating an additional rate constant kvo, can characterize the delay between the arterial and venous sampling site. Significant hysteresis was observed in the arterial but not the venous concentration-effect relationships. Rate constants for keo, kvo and terminal half-life were (mean ± S.E.M.) 0.32 ± 0.062, 0.093 ± 0.013 and 0.0217 ± 0.0008 min-1, respectively, indicating the existence of significant arteriovenous concentration differences. Pharmacodynamic estimates as determined on basis of the arterial concentrations and the traditional-effect compartment model were EC50 = 104 ± 1 ng/ml, Emax = 151 ± 4 µV/sec and gamma  = 0.83 ± 0.06. Analysis of the venous concentration-effect relationships on basis of the traditional- or extended-effect compartment model led to similar pharmacodynamic estimates, indicating that the observed arteriovenous concentration differences did not result in biased pharmacodynamic estimates. This is due to the fact that the effect relevant elimination rate constant of midazolam is relatively small compared with its keo. The observed results are consistent with earlier reports based on computer simulations.


0022-3565/98/2841-0202$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. Yassen, E. Olofsen, A. Dahan, and M. Danhof
Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effect of Buprenorphine and Fentanyl in Rats: Role of Receptor Equilibration Kinetics
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1136 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
R. N. Upton, G. L. Ludbrook, A. M. Martinez, C. Grant, and R. W. Milne
Cerebral and lung kinetics of morphine in conscious sheep after short intravenous infusions
Br. J. Anaesth., June 1, 2003; 90(6): 750 - 758.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Ibrahim, A. Karim, J. Feldman, and E. Kharasch
The Influence of Parecoxib, a Parenteral Cyclooxygenase-2 Specific Inhibitor, on the Pharmacokinetics and Clinical Effects of Midazolam
Anesth. Analg., September 1, 2002; 95(3): 667 - 673.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. de Roode, J. M. A. van Gerven, R. C. Schoemaker, F. H. M. Engbers, W. Olieman, J. R. Kroon, A. F. Cohen, and J. G. Bovill
A Comparison of the Effects of Propofol and Midazolam on Memory During Two Levels of Sedation by Using Target-Controlled Infusion
Anesth. Analg., November 1, 2000; 91(5): 1056 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Christiaens, C. Janssenswillen, C. Verborgh, I. Moerman, P. Devroey, A. Van Steirteghem, and F. Camu
Propofol concentrations in follicular fluid during general anaesthesia for transvaginal oocyte retrieval
Hum. Reprod., February 1, 1999; 14(2): 345 - 348.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.